Manufacturer profile

LEICA BIOSYSTEMS NEWCASTLE LTD

Indonesia flagIndonesia·United Kingdom·20 products registered
20
Total Products
20
Product Names
2
Product Classes
2
Risk Classes
Risk classification breakdown

Distribution of products across risk classes

Kelas Resiko : A
12
60.0% of total
Kelas Resiko : B
8
40.0% of total
Product class portfolio

Products organized by product class

Recent registrations (20 most recent)

Most recently registered products with BPOM

LEICA Novocastra ™ Liquid Mouse Monoclonal Antibody Inhibin AlphaFeb 10, 2025
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND™ Multi-Cytokeratin (AE1/AE3)Oct 25, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND™ Ready-to-Use Primary Antibody PMS2 (Mismatch Repair Protein) (EP51)Oct 10, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND™ Ready-to-Use Primary Antibody MSH2 (Mismatch Repair Protein) (79H11)Oct 9, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND™ Ready-to-Use Primary Antibody MLH1 (Mismatch Repair Protein) (ES05)Oct 8, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA Novocastra Liquid Mouse Monoclonal Antibody CD21Oct 6, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND™ Ready-to-Use Primary Antibody MSH6 (Mismatch Repair Protein) (EP49)Oct 6, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND Ready-to-Use Primary Antibody CD30 (JCM182)Oct 4, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND Oracle HER2 IHC SystemOct 4, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND Ready-to-Use Primary Antibody Synaptophysin (27G12)Sep 29, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND Ready-to-Use Primary Antibody Terminal Deoxynucleotidyl Transferase (SEN28)Sep 29, 2023
Class: Kelas : 2
Risk Class: Kelas Resiko : B
LEICA BOND Ready-to-Use Primary Antibody Myosin Heavy Chain (smooth muscle) (S131)Sep 29, 2023
Class: Kelas : 2
Risk Class: Kelas Resiko : B
LEICA BOND ™ Ready-to-Use Primary Antibody Melan A (A103)Sep 26, 2023
Class: Kelas : 2
Risk Class: Kelas Resiko : B
LEICA BOND™ Ready-to-Use Primary Antibody CD15 (MMA)Sep 25, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
LEICA BOND™ Ready-to-Use Primary Antibody Alpha-Methylacyl-CoA Racemase (EPMU1)Sep 25, 2023
Class: Kelas : 2
Risk Class: Kelas Resiko : B
LEICA BOND Ready-to-Use Primary Antibody E-Cadherin (36B5)Sep 25, 2023
Class: Kelas : 2
Risk Class: Kelas Resiko : B
LEICA BOND™ Ready-to-Use Primary Antibody CD31 (JC70A)Sep 25, 2023
Class: Kelas : 2
Risk Class: Kelas Resiko : B
LEICA BOND™ Ready-to-Use Primary Antibody Muscle Specific Actin (HHF35)Sep 22, 2023
Class: Kelas : 2
Risk Class: Kelas Resiko : B
LEICA BOND™ Ready-to-Use Primary Antibody Cytokeratin (AE1/AE3)Sep 22, 2023
Class: Kelas : 2
Risk Class: Kelas Resiko : B
LEICA BOND Ready-To-Use Primary Antibody Myf-4 (Rhabdomyosarcoma Marker) (L026)Sep 22, 2023
Class: Kelas : 1
Risk Class: Kelas Resiko : A
About this profile

LEICA BIOSYSTEMS NEWCASTLE LTD from United Kingdom is a medical device manufacturer with 20 registered products in the Indonesia BPOM database through Pure Global AI's free platform. The company produces 20 unique product types across 2 product classes.

This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.

Free Manufacturer ProfilePowered by Pure Global AI20 Products2 Classes